Literature DB >> 16210365

Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element.

Jeffrey A Magee1, Li-wei Chang, Gary D Stormo, Jeffrey Milbrandt.   

Abstract

Androgen signaling via the androgen receptor (AR) transcription factor is crucial to normal prostate homeostasis and prostate tumorigenesis. Current models of AR function are predominantly based on studies of prostate-specific antigen regulation in androgen-responsive cell lines. To expand on these in vitro paradigms, we used the mouse prostate to elucidate the mechanisms through which AR regulates another direct target, FKBP5, in vivo. FKBP5 encodes an immunophilin that has been previously implicated in glucocorticoid and progestin signaling pathways and that likely influences prostate physiology in the presence of androgens. In this work, we show that androgens directly regulate FKBP5 via an interaction between the AR and a distal enhancer located 65 kb downstream of the transcription start site in the fifth intron of the FKBP5 gene. We have found that AR selectively recruits cAMP response element-binding protein to this enhancer. These interactions, in turn, result in chromatin remodeling that affects the enhancer proper but not the FKBP5 locus as a whole. Furthermore, in contrast to prostate-specific antigen-regulatory mechanisms, we show that transactivation of the FKBP5 gene does not rely on a single looping complex to mediate communication between the distal enhancer and proximal promoter. Rather, the distal enhancer complex and basal transcription apparatus communicate indirectly with one another, implicating a regulatory mechanism that has not been previously appreciated for AR target genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210365     DOI: 10.1210/en.2005-1001

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  82 in total

Review 1.  Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.

Authors:  Anthony S Zannas; Tobias Wiechmann; Nils C Gassen; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2015-08-13       Impact factor: 7.853

2.  6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.

Authors:  Ajeeth K Pingili; Mehmet Kara; Nayaab S Khan; Anne M Estes; Zongtao Lin; Wei Li; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

3.  A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

Authors:  Qianben Wang; Wei Li; X Shirley Liu; Jason S Carroll; Olli A Jänne; Erika Krasnickas Keeton; Arul M Chinnaiyan; Kenneth J Pienta; Myles Brown
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

4.  CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.

Authors:  Michael A Augello; Deli Liu; Lesa D Deonarine; Brian D Robinson; Dennis Huang; Suzan Stelloo; Mirjam Blattner; Ashley S Doane; Elissa W P Wong; Yu Chen; Mark A Rubin; Himisha Beltran; Olivier Elemento; Andries M Bergman; Wilbert Zwart; Andrea Sboner; Noah Dephoure; Christopher E Barbieri
Journal:  Cancer Cell       Date:  2019-03-28       Impact factor: 31.743

5.  Androgen-responsive gene database: integrated knowledge on androgen-responsive genes.

Authors:  Mei Jiang; Yunsheng Ma; Congcong Chen; Xuping Fu; Shu Yang; Xia Li; Guohua Yu; Yumin Mao; Yi Xie; Yao Li
Journal:  Mol Endocrinol       Date:  2009-09-17

6.  Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.

Authors:  Päivi Pihlajamaa; Biswajyoti Sahu; Lauri Lyly; Viljami Aittomäki; Sampsa Hautaniemi; Olli A Jänne
Journal:  EMBO J       Date:  2014-01-22       Impact factor: 11.598

7.  Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Authors:  Varadha Balaji Venkadakrishnan; Adam D DePriest; Sangeeta Kumari; Dhirodatta Senapati; Salma Ben-Salem; Yixue Su; Giridhar Mudduluru; Qiang Hu; Eduardo Cortes; Elena Pop; James L Mohler; Gissou Azabdaftari; Kristopher Attwood; Rajal B Shah; Christina Jamieson; Scott M Dehm; Cristina Magi-Galluzzi; Eric Klein; Nima Sharifi; Song Liu; Hannelore V Heemers
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

8.  DNA methylation and sex-specific expression of FKBP5 as correlates of one-month bedtime cortisol levels in healthy individuals.

Authors:  Richard S Lee; Pamela B Mahon; Peter P Zandi; Mary E McCaul; Xiaoju Yang; Utsav Bali; Gary S Wand
Journal:  Psychoneuroendocrinology       Date:  2018-07-04       Impact factor: 4.905

9.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

10.  Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries.

Authors:  Tammy L Romanuik; Gang Wang; Robert A Holt; Steven J M Jones; Marco A Marra; Marianne D Sadar
Journal:  BMC Genomics       Date:  2009-10-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.